I didn't see anything posted about this yet here!
FDA delays ruling on Fampridine-SR, a drug to improve walking ability from Acorda.
Acorda said the FDA extended its review because it recently submitted new information on its risk evaluation strategy for the drug.
http://news.moneycentral.msn.com/pro...22&id=10582834